The Patients You Already Paid to Acquire Are Sitting in Your CRM

No one can tell you reliably what a new MedSpa patient costs — the two most-citable figures disagree sharply, and neither is an industry average. What is well measured is that most MedSpa patients are repeat patients. The growth channel where the acquisition cost is already spent is the dormant list you already own, if you have the infrastructure to work it.

Ed

AI receptionist, Pillar 3 Reactivation, patient retention, MedSpa, dormant patients

The Patients You Already Paid to Acquire Are Sitting in Your CRM




Nobody can tell you what a new patient actually costs




Ask five vendors what it costs a MedSpa to acquire a new patient and you will get five numbers, none of which will arrive with a sample size attached.




We went looking for the real answer. Here is everything we could actually stand behind:

  • ~$285 per patient — First Page Sage's anonymized client database, 2021–2025. It is the only source we found that discloses its methodology and publishes its sample size. That sample is eight MedSpas.

  • $132 per new patient, against a $527 average visit value — published by the American Med Spa Association, reporting Growth99's 2026 State of Aesthetic & Elective Wellness Marketing Report.

Those two figures disagree sharply. Both publishers sell the service the number justifies. Neither is an industry average, and we are not going to present either one as though it were.




That is not a footnote. It is the finding. If you cannot pin down what a new patient costs you, every dollar of your growth plan is being allocated on a guess. And the one growth channel where you don't have to guess — where the acquisition cost is already spent, and the patient has already said yes to you once — is the one almost nobody works.




A note on two numbers we removed from this page. An earlier version of this article claimed MedSpa patient acquisition costs had sharply increased over recent years, and quoted a per-patient cost range. We traced both. The increase claim rests on a single page that publishes no dataset and no comparator — and no publisher anywhere produces a paired, like-for-like MedSpa figure across those years. The cost range is real, but its population is dermatology, orthopedics and ENT; MedSpas appear nowhere in it. We pulled both. We would rather correct our own page than repeat a number we can't stand behind.




The leak is invisible because nothing breaks




Reactivation is the quietest of the revenue leaks because nothing actually fails. The phone still rings. New patients still book. The calendar looks busy. What's missing is the patient who came in for a single Botox cycle in September, loved it, fully intended to come back, and simply never got a reason to. No one called. No one noticed. She's not a complaint or a cancellation — she's just gone.




And she is not a marginal asset. AmSpa's 2024 State of the Industry report found that an average of 73% of medical spa patients are repeat patients, up from 65% in AmSpa's prior (2022) report. On average, in other words, nearly three in four MedSpa patients are repeat patients. A dormant list is by definition the part of a base that isn't behaving that way — and nothing in a typical practice is built to notice it.




This is the Pillar 3 problem — what The Thinking Robot calls the Autonomous Reactivation Engine. Most practices have a CRM full of dormant names and no infrastructure to bring those people back. The list exists. The intent exists. The mechanism to act on it, across the full list, in a voice that sounds like the practice rather than a mass blast, does not.




Why 2026 is the year this stops being optional




When you can't measure acquisition cost, you can't optimize it — you can only spend into it and hope. Retention is the part of the funnel where the economics are legible: you know who the patient is, you know what she booked, you know what she paid, and you know exactly how long it's been.




Retention isn't a loyalty discount or a quarterly newsletter. It's an operational system that knows when a patient has gone quiet and does something specific about it before the relationship cools past saving.




The only acquisition cost you can actually verify




You will notice we are not printing a projection here. We could — every vendor in this category will hand you a slider and a number inside thirty seconds. We don't, because a revenue figure attached to a practice we have never audited is an assertion, not arithmetic.




What we can do is put the two costs side by side, per patient.




A new patient costs whatever your own market and channel mix make it cost. One agency's eight-practice dataset puts it near $285. AmSpa-published reporting of Growth99's survey puts it near $132. The next vendor you ask will say something else again. You cannot pin it down. It is definitely not zero.




A dormant patient costs nothing to acquire. You already paid it. That invoice cleared the first time she walked through the door.




That is the entire argument, and it doesn't need a model to hold it up. If you want the size of the opportunity inside your own practice, the arithmetic is yours to run and the inputs are yours to supply: how many patients haven't booked in 90 days, what share of them a disciplined 4-touch sequence would realistically bring back, and what your own average revisit ticket actually is. We are not going to hand you those three numbers, because we have not measured your practice.




What Lifelike Automations do with a dormant list




Here's the mechanism. The Thinking Robot installs Revenue Recovery Infrastructure, and we build it as Lifelike Automations — agents trained on your practice and embedded in your stack. Zeno handles booking-system checks and scheduled outreach. The dormancy threshold is configured to your practice; when a patient passes it without a future appointment, she enters a personalized win-back sequence timed to her own treatment cycle rather than a generic "we miss you" blast — the message references the relationship and the timing, not the clinical detail, which stays in your systems. For practices that require it, the sequence is built to run inside a HIPAA-Compliant, BAA-eligible (Business Associate Agreement) deployment. For high-value patients who ignore text and email, a voice agent places a warm conversational check-in call offering a real reason to return, not a discount carpet-bomb. Rosey answers the inbound line when those patients call back to rebook.




This is not a mailing list with a calendar reminder bolted on. It's a trained extension of your front office that does the one thing a busy practice never has time to do by hand: notice that a specific valuable patient went quiet, and reach out in a voice that sounds like you — while your human team stays on the patients in the chair. The intake side of that same lifecycle is covered in our breakdown of cosmetic consult intake protocols.




You don't have an acquisition problem you can spend your way out of — you have an acquisition number you can't even verify. What you do have is a retention asset you've never been equipped to work. The list is already yours. The only question is whether anything in your practice is built to bring those people home.




References




  • MedSpa patient acquisition cost — the honest state of the evidence. First Page Sage, Average Patient Acquisition Cost (pub. 2024-07-31, mod. 2025-12-23): ~$285, anonymized client database, n=8 MedSpas, 2021–2025. American Med Spa Association, The Marketing Investment Gap (9 Jan 2026), reporting Growth99's 2026 State of Aesthetic & Elective Wellness Marketing Report: $132 new-patient acquisition against a $527 average visit value. Both publishers sell services the figures justify; neither figure is an industry average.

  • 73% of medical spa patients are repeat patients, up from 65% in the prior (2022) report. American Med Spa Association, 2024 Medical Spa State of the Industry, Executive Report recap (free summary; full report paywalled). Fieldwork Sep 2023 – Mar 2024. The denominator is patients, not visits.

  • 90-day dormancy threshold and 4-touch sequence — The Thinking Robot internal Autonomous Reactivation Engine specification (Pillar 3 baseline). Internal operating definitions, not industry standards.

  • No revenue projection appears on this page.

  • Botox is a registered trademark of Allergan. Product names are used descriptively; no affiliation or endorsement is implied.

Removed 2026-08-19 as unsubstantiated: an asserted multi-year increase in MedSpa acquisition cost; a per-patient cost range whose population is not MedSpas; a growth-rate comparison between lifecycle-automation clinics and others; and a modelled reactivation revenue figure.




Next Step

If your premium practice runs more than 150 inbound calls a month and has no structured measurement of how many never reach a scheduled consultation, you have no way to know whether your pipeline is leaking — which is the first thing worth fixing.

We look at that directly in an Intake Leak Audit: we call your main line after hours, document what actually happened, and send you a written leak report within 48 hours. The report's dollar figures are illustrative estimates built from your own inputs, not a forecast of your results.